John Chrystal - 13 Nov 2025 Form 4 Insider Report for Gen Digital Inc. (GEN)

Role: Director
Signature: /s/ Kathryn White, as attorney-in-fact for John Chrystal
Issuer symbol: GEN
Transactions as of: 13 Nov 2025
Transactions value $: $135,693
Form type: 4
Filing time: 14 Nov 2025, 17:16:56
Previous filing: 01 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Chrystal John C	Director	60 E. RIO SALADO PARKWAY, SUITE 1000, TEMPE	/s/ Kathryn White, as attorney-in-fact for John Chrystal	13 Nov 2025	0001559369

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GEN	Common Stock	Purchase	$136K	+5K	+21.35%	$27.14	28.4K	13 Nov 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	GEN	GEN Contingent Value Rights						51.1K	13 Nov 2025	Common Stock	51.1K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pursuant to the Contingent Value Rights Agreement dated April 17, 2025, (the CVR Agreement"), each GENVR share entitles the holder a conditional payment of $23.00 in Gen Digital Inc.'s common stock (GEN), par value $0.01 per share, if, on any date prior to April 17, 2027, (i) each GEN share trades at an average volume-weighted price of at least $37,50 per share for more than 30 consecutive trading days within the period from December 10, 2024 to April 17, 2027 or (ii) Gen undergoes a change of control.

Content

Pursuant to the Contingent Value Rights Agreement dated April 17, 2025, (the CVR Agreement"), each GENVR share entitles the holder a conditional payment of $23.00 in Gen Digital Inc.'s common stock (GEN), par value $0.01 per share, if, on any date prior to April 17, 2027, (i) each GEN share trades at an average volume-weighted price of at least $37,50 per share for more than 30 consecutive trading days within the period from December 10, 2024 to April 17, 2027 or (ii) Gen undergoes a change of control.